Wikipedia -WSS

Wikipedia

author：hotspot 2025-08-26 10:54:20 - browse：5

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Drinking less cuts risk of oral cavity, esophageal cancer: Report

focus

WSS

In Spain, a hospital brews its own CAR

Patient advocates sound warning on FDA proposal on salt intake

As Maui death toll rises, number of missing remains unclear

Keeping primary care docs in field isn't impossible, says AAFP CEO

Beware the threat of staffing cuts at the CDC

Ukraine taking heavy casualties 10 weeks into its counteroffensive

hotspot

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

New air purifier tech could be key to improving indoor air quality

Carvykti CAR

Sports medicine is finally prioritizing gender equality

Christmas in the PICU brings some surprising joy

Psychedelics group wrestles with new pharma identity

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Medicare proposal to cover medical devices draws a mixed reaction

An interview with Robert F. Kennedy Jr. on vaccines

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Three trends to watch in biotech in 2024

knowledge

Why health records don't always know when patients are dead

Grail spinoff by Illumina should end disastrous merger attempt

Why health records don't always know when patients are dead

How to keep neuroscience’s past racism from being its future

HCA sued by state AG for quality issues at Mission Health

Medicare Advantage beneficiaries sue Humana over algorithm use

focus

focus

explore

Wikipedia